Synthetic cannabinoid receptor agonists are monoamine oxidase-A selective inhibitors. (2023)

First Author: Hindson SA
Attributed to:  BrisSynBio: Bristol Centre for Synthetic Biology funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/febs.16741

PubMed Identifier: 36708234

Publication URI: http://europepmc.org/abstract/MED/36708234

Type: Journal Article/Review

Volume: 290

Parent Publication: The FEBS journal

Issue: 12

ISSN: 1742-464X